North America Immunotoxins Market Size & Outlook

The immunotoxins market in North America is expected to reach a projected revenue of US$ 99.1 million by 2030. A compound annual growth rate of 7.9% is expected of North America immunotoxins market from 2025 to 2030.
Revenue, 2024 (US$M)
$63.3
Forecast, 2030 (US$M)
$99.1
CAGR, 2025 - 2030
7.9%
Report Coverage
North America

North America immunotoxins market, 2018-2030 (US$M)

North
Unlock Premium

North America immunotoxins market highlights

  • The North America immunotoxins market generated a revenue of USD 63.3 million in 2024.
  • The market is expected to grow at a CAGR of 7.8% from 2025 to 2030.
  • In terms of segment, diphtheria toxin (dt) was the largest revenue generating product in 2024.
  • Diphtheria Toxin (DT) is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2030.

North America data book summary

Market revenue in 2024USD 63.3 million
Market revenue in 2030USD 99.1 million
Growth rate7.8% (CAGR from 2025 to 2030)
Largest segmentDiphtheria toxin (dt)
Fastest growing segmentDiphtheria Toxin (DT)
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDiphtheria Toxin (DT), Anthrax Based Toxins, Pseudomonas Exotoxin (PE), Other Immunotoxins
Key market players worldwideCreative-Biolabs, The Native Antigen Company, Bio-Techne Corp, Abcam PLC, Cayman Chemical, Merck KGaA, Enzo Biochem Inc, Santa Cruz Biotechnology (SCBT)

Other key industry trends

  • In terms of revenue, North America region accounted for 41.4% of the global immunotoxins market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 49.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunotoxins Market Scope

Immunotoxins market segmentation & scope
Countries
U.S.
Canada
Mexico
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
China
Japan
India
South Korea
Australia
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Immunotoxins Market Companies

Name Profile # Employees HQ Website

North America immunotoxins market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunotoxins market will help companies and investors design strategic landscapes.


Diphtheria toxin (dt) was the largest segment with a revenue share of 42.65% in 2024. Horizon Databook has segmented the North America immunotoxins market based on diphtheria toxin (dt), anthrax based toxins, pseudomonas exotoxin (pe), other immunotoxins covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America immunotoxins market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America immunotoxins market databook

  • Our clientele includes a mix of immunotoxins market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America immunotoxins market , including forecasts for subscribers. This continent databook contains high-level insights into North America immunotoxins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America immunotoxins market size, by country, 2018-2030 (US$M)

North America Immunotoxins Market Outlook Share, 2024 & 2030 (US$M)

North America immunotoxins market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more